Next-generation sequencing for identifying a novel/de novo pathogenic variant in a Mexican patient with cystic fibrosis: a case report
Open Access
- 22 May 2019
- journal article
- case report
- Published by Springer Nature in BMC Medical Genomics
- Vol. 12 (1) , 68
Abstract
Mexico is among the countries showing the highest heterogeneity of CFTR variants. However, no de novo variants have previously been reported in Mexican patients with cystic fibrosis (CF). Here, we report the first case of a novel/de novo variant in a Mexican patient with CF. Our patient was an 8-year-old male who had exhibited the clinical onset of CF at one month of age, with steatorrhea, malabsorption, poor weight gain, anemia, and recurrent respiratory tract infections. Complete sequencing of the CFTR gene by next generation sequencing (NGS) revealed two different variants in trans, including the previously reported CF-causing variant c.3266G > A (p.Trp1089*, W1089*), that was inherited from the mother, and the novel/de novo CFTR variant c.1762G > T (p.Glu588*). Our results demonstrate the efficiency of targeted NGS for making a rapid and precise diagnosis in patients with clinically suspected CF. This method can enable the provision of accurate genetic counselling, and improve our understanding of the molecular basis of genetic diseases.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (819707)
This publication has 31 references indexed in Scilit:
- A New Targeted CFTR Mutation Panel Based on Next-Generation Sequencing TechnologyThe Journal of Molecular Diagnostics, 2017
- A new insight into CFTR allele frequency in Brazil through next generation sequencingPediatric Pulmonology, 2017
- CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rareCFTRvariantsHuman Mutation, 2017
- The importance of functional tests to assess the effect of a new
CFTR
variant when genotype–phenotype correlation is not possibleClinical Case Reports, 2017
- Cystic fibrosis in Latin America—Improving the awarenessJournal of Cystic Fibrosis, 2016
- The Impact on Genetic Testing of Mutational Patterns of CFTR Gene in Different Clinical Macrocategories of Cystic FibrosisThe Journal of Molecular Diagnostics, 2016
- Identification and frequencies of cystic fibrosis mutations in central ArgentinaClinical Biochemistry, 2016
- Tobramycin is a suppressor of premature termination codonsJournal of Cystic Fibrosis, 2013
- Distribution of CFTR mutations in the Czech population: Positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populationsJournal of Cystic Fibrosis, 2013
- Translational readthrough induction of pathogenic nonsense mutationsEuropean Journal of Medical Genetics, 2006